The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan

被引:34
作者
Asai, Nobuhiro [1 ,2 ]
Sakanashi, Daisuke [2 ]
Suematsu, Hiroyuki [2 ]
Kato, Hideo [2 ]
Hagihara, Mao [2 ]
Nishiyama, Naoya [2 ]
Koizumi, Yusuke [1 ,2 ]
Yamagishi, Yuka [1 ,2 ]
Mikamo, Hiroshige [1 ,2 ]
机构
[1] Aichi Med Univ Hosp, Dept Clin Infect Dis, Nagakute, Aichi, Japan
[2] Aichi Med Univ Hosp, Dept Infect Control & Prevent, Nagakute, Aichi, Japan
关键词
Carbapenems; Enterobacteriaceae; Drug-resistant; Risk factors; IMP; METALLO-BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; MORTALITY; PREDICTORS; THERAPY; MULTICENTER; ACQUISITION; KOREA;
D O I
10.1016/j.jiac.2018.02.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: While the emergence and spread of carbapenem-resistant enterobacteriaceae (CRE) carriage and infections are serious threats to public health worldwide, its prevalence and epidemiology are still unknown. Methods and Patients: For the purpose of examining the prevalence, patients' background and risk factors for CRE carriage and infections, we conducted this case-control study. We retrospectively reviewed all patients isolating CRE at Aichi Medical University hospital from January 2010 until March 2017. The patients isolated with carbapenem-susceptible enterobacteriaceae (CSE) were randomly selected during the study period. Results: A total of 26 patients, isolating 28 CRE infections were enrolled in this study. The detection rate of CRE carriage and infection was 0.22% (28/12,600). Compared to the CSE group, the CRE group had poorer PS and higher CCI scores. The CRE group tended to stay longer in hospital (121 v.s. 63 days, p = 0.052) and admission fee was much more expensive than CSE group (220,710 v.s. 69,904 JPY, p < 0.001). PS 2-4 (ECOG) and CCI >= 3 (p = 0.002), prior hospitalization within 90 days (p = 0.006) and prior antibiotics use within 90 days (p = 0.005) were risk factors for acquisition of CRE by univariate analysis. The combination of PS 2-4 and CCI >= 3 was an independent risk factor for CRE carriage and infection by multivariate logistic regression analysis. Conclusion: The combination of PS 2-4 (ECOG) and CCI score >= 3 was an independent risk factor of CRE carriage and infections. The CRE group tended to stay longer in hospital, and the medical expense was much more expensive than those in the CSE group. (c) 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:505 / 509
页数:5
相关论文
共 35 条
[1]   Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: A matched case-control study [J].
Ahn, Jin Young ;
Song, Je Eun ;
Kim, Min Hyung ;
Choi, Heun ;
Kim, Jae Kyung ;
Ann, Hea Won ;
Kim, Jung Ho ;
Jeon, Yongduk ;
Jeong, Su Jin ;
Kim, Sun Bean ;
Ku, Nam Su ;
Han, Sang Hoon ;
Song, Young Goo ;
Yong, Dongeun ;
Lee, Kyungwon ;
Kim, June Myung ;
Choi, Jun Yong .
AMERICAN JOURNAL OF INFECTION CONTROL, 2014, 42 (06) :621-625
[2]  
Ampaire Lucas M, 2015, Br Microbiol Res J, V8, P418, DOI 10.9734/BMRJ/2015/17055
[3]  
[Anonymous], 2012, PERFORMANCE STANDARD
[4]   Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States [J].
Bartsch, S. M. ;
McKinnell, J. A. ;
Mueller, L. E. ;
Miller, L. G. ;
Gohil, S. K. ;
Huang, S. S. ;
Lee, B. Y. .
CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (01) :48.e9-48.e16
[5]   Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae [J].
Bulik, Catharine C. ;
Nicolau, David P. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) :3002-3004
[6]   Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe [J].
Canton, R. ;
Akova, M. ;
Carmeli, Y. ;
Giske, C. G. ;
Glupczynski, Y. ;
Gniadkowski, M. ;
Livermore, D. M. ;
Miriagou, V. ;
Naas, T. ;
Rossolini, G. M. ;
Samuelsen, O. ;
Seifert, H. ;
Woodford, N. ;
Nordmann, P. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (05) :413-431
[7]   Successful Ertapenem-Doripenem Combination Treatment of Bacteremic Ventilator-Associated Pneumonia Due to Colistin-Resistant KPC-Producing Klebsiella pneumoniae [J].
Ceccarelli, Giancarlo ;
Falcone, Marco ;
Giordano, Alessandra ;
Mezzatesta, Maria Lina ;
Caio, Carla ;
Stefani, Stefania ;
Venditti, Mario .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (06) :2900-2901
[8]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[9]   A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection [J].
Correa, Luci ;
Martino, Marines Dalla Valle ;
Siqueira, Itacy ;
Pasternak, Jacyr ;
Gales, Ana Cristina ;
Silva, Claudia Vallone ;
Sampaio Camargo, Thiago Zinsly ;
Scherer, Patricia Faria ;
Marra, Alexandre Rodrigues .
BMC INFECTIOUS DISEASES, 2013, 13
[10]   How to measure comorbidity: a critical review of available methods [J].
de Groot, V ;
Beckerman, H ;
Lankhorst, GJ ;
Bouter, LM .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (03) :221-229